Swakowska Katarzyna, Religioni Urszula, Staniszewska Anna
Civitas 24 GmbH, 55122 Mainz, Germany.
School of Public Health, Centre of Postgraduate Medical Education of Warsaw, 01-826 Warsaw, Poland.
Healthcare (Basel). 2023 Oct 12;11(20):2717. doi: 10.3390/healthcare11202717.
The majority of medicines used in Poland are generic drugs and substitutions of the originals. The objective of this study was to obtain information on the current knowledge about generic medicines among Polish patients with epilepsy.
The conducted study was based on a self-developed questionnaire. The questionnaire consisted of 26 questions, including the questions regarding the respondents' knowledge about generics, their previous experience, and the factors behind these choices.
Overall, 1220 questionnaires were analyzed. Among all patients, 66.4% reportedly had heard about generics. Of these, 61.5% of patients had used generic drugs in the past. A significant proportion of participants had never been recommended to switch to a generic medicine by their healthcare professional (23% physicians and 13.9% pharmacists). Statistically, relevant differences were observed regarding the respondents' kind and level of education, place of residence, and net income per household.
Significant gaps were identified in the knowledge and perceptions among patients regarding generic medicines, especially in relation to their efficacy and safety. Efforts must be directed towards increasing public awareness of generic medicines and there should also be a focus on educating patients about generic medicines.
波兰使用的大多数药物都是仿制药及其原研药的替代产品。本研究的目的是获取波兰癫痫患者对仿制药当前认知情况的信息。
所开展的研究基于一份自行编制的问卷。该问卷包含26个问题,包括有关受访者对仿制药的了解、他们之前的使用经历以及这些选择背后的因素等问题。
总体而言,共分析了1220份问卷。在所有患者中,据报告66.4%听说过仿制药。其中,61.5%的患者过去使用过仿制药。很大一部分参与者从未被其医疗保健专业人员(23%的医生和13.9%的药剂师)建议改用仿制药。在统计学上,观察到受访者的教育类型和水平、居住地点以及每户家庭净收入方面存在显著差异。
在患者对仿制药的认知和看法方面发现了显著差距,尤其是在其疗效和安全性方面。必须致力于提高公众对仿制药的认识,还应注重对患者进行仿制药知识教育。